Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Elizabeth A. Farrington"'
Autor:
Mark Wright, Robert Przemioslo, Joe Hickey, Melanie Kent, Elizabeth Anne Farrington, Stephen D. Ryder, Paul G. Richardson, Richard Aspinall, Mark Hudson, F P Porras Perez, Bharat Amlani, Debbie L. Shawcross
Publikováno v:
Posters.
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 24:421-430
OBJECTIVES Accurate determination of ideal body weight (IBW) in pediatric patients is important for the proper dosing of many medications and the classification of nutritional status. There is no consensus on the best method to calculate IBW. The pur
Autor:
Elizabeth Anne Farrington, Carol L. Braunschweig, Praveen S. Goday, Sharon Y. Irving, Heather E. Skillman, Nilesh M. Mehta, Sarah Vermilyea, Liam McKeever, Amber M. Hall, Jorge A. Coss-Bu
Publikováno v:
Journal of Parenteral and Enteral Nutrition. 41:706-742
This document represents the first collaboration between two organizations, American Society of Parenteral and Enteral Nutrition and the Society of Critical Care Medicine, to describe best practices in nutrition therapy in critically ill children. Th
Autor:
John F. Dillon, A. Radwan, Paul G. Richardson, Mark Hudson, Stephen D. Ryder, Mark Wright, William Jonathan Cash, Sushma Saksena, Paola Di Maggio, Elizabeth Anne Farrington, Michael Allison, Debbie L. Shawcross, Robert T Przemioslo, Richard Aspinall, Riccardo Cipelli, Rajiv Jalan
Publikováno v:
Frontline Gastroenterology
Objective To compare all-cause and liver-related hospital resource use in the 6 and 12 months pre-rifaximin-α and post-rifaximin-α initiation in UK patients with hepatic encephalopathy (HE). Design A UK multicentre, retrospective, observational stu
Study participants (N = 348) were asked about 46 reasons that have been suggested for why people use or do not use condoms. Participants were asked which of these reasons motivated them when they were deciding whether to use condoms in 503 sexual rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a680e50d068d0f2973b119442e3efd
https://europepmc.org/articles/PMC5720389/
https://europepmc.org/articles/PMC5720389/
Autor:
Joseph M. LaRochelle, David S. Hoff, Richard H. Parrish, Allison M. Chung, Hanna Phan, Rebecca S. Pettit, Varsha Bhatt-Mehta, Amy L. Potts, Katherine P. Smith, Tracy M. Hagemann, Marcia L. Buck, Elizabeth Anne Farrington
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 33:243-251
Children warrant access to care from clinical pharmacists trained in pediatrics. The American College of Clinical Pharmacy Pediatrics Practice and Research Network (ACCP Pediatrics PRN) released an opinion paper in 2005 with recommendations for impro
Publikováno v:
Frontline Gastroenterology. 3:187-190
The demand for collaborative and innovative clinical practitioners to act as leaders in healthcare remains strong as many challenges are faced including rising costs, shortage of professionals, the introduction of new technology and difficulties with
Autor:
Patrick E. Gipson, William Conley, Debbie S. Gipson, Tsz Yin So, Kara Bozik, Elizabeth A. Farrington, Maria E. Ferris, Keisha L. Gibson, J. Bradley Layton, William A. Primack
Publikováno v:
Renal Failure. 33:19-25
Purpose: Pediatric patients require special attention from pediatric pharmacists. This is particularly true for pediatric patients with chronic kidney disease (CKD) as the number of their medications and the complexity of their treatment increase wit
Publikováno v:
Expert Opinion on Drug Safety. 6:673-684
Drug-induced liver injury (DILI) encompasses a spectrum of clinical disease ranging from mild biochemical abnormalities to acute liver failure. The majority of adverse liver reactions are idiosyncratic, occurring in most instances 5-90 days after the
Publikováno v:
Expert opinion on drug safety. 13(1)
Idiosyncratic drug induced liver injury (DILI) is rare, with an incidence of approximately 19 per 100,000 treated individuals.An update on the epidemiology, pathogenic mechanisms, diagnosis, outcome, risk factors for idiosyncratic drug-induced hepato